Penserra Capital Management LLC Galapagos Nv Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$47.03 - $57.12 $10,111 - $12,280	-215 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$52.17 - $70.2 $2,608 - $3,510	50 Added 30.3%	215 $11,000
Q2 2021 Aug 12, 2021	BUY	$68.86 - $83.34 $3,098 - $3,750	45 Added 37.5%	165 $11,000
Q1 2021 May 13, 2021	SELL	$76.15 - $111.94 $2,665 - $3,917	-35 Reduced 22.58%	120 $9,000
Q4 2020 Feb 12, 2021	BUY	$96.85 - $148.25 $9,007 - $13,787	93 Added 150.0%	155 $15,000
Q3 2020 Nov 13, 2020	BUY	$122.47 - $213.56 $7,593 - $13,240	62 New	62 $8,000

12.2M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.5B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.